
Canopy Growth (CGC) shares soared about 18% on Monday after President Donald Trump endorsed cannabidiol (CBD) as a potential breakthrough in senior healthcare.
CBD could “revolutionize senior healthcare,” Trump wrote on Truth Social over the weekend, reigniting speculation that marijuana may be reclassified under his administration.